Clinical colorectal cancer

Clinical Colorectal Cancer is devoted to manuscripts on early detection and screening, diagnosis, prevention and treatment of colorectal cancer and other gastrointestinal cancers, including pancreatic, liver, gastric and gastro-oesophageal, biliary and other GI tumours. Its aims and scope emphasise original peer-reviewed reports of clinical research and of translational correlative science directly related to clinical trials, across all multidisciplinary therapeutic fields, plus research on drug sensitivity and resistance to cytotoxic, targeted and immune therapies, pathology, validated predictive markers and prognostic indicators, chemoprevention and integration of therapeutic approaches. Meta-analyses, pooled analyses and real-world analyses receive lower priority unless clearly applicable to practice, and unsolicited reviews are discouraged without prior discussion with the editor. ScienceDirect lists the journal as supporting open access, offering authors a choice of open access or subscription publication. NLM records the title from 2001, first published in Dallas by the Cancer Information Group and from 2011 by Elsevier, quarterly, indexed in MEDLINE and PubMed.